0730 Samelisant (SUVN-G3031) Demonstrates Significant Reduction in Excessive Daytime Sleepiness in Patients with Narcolepsy: Phase-2 Results
Year: 2026
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: SLEEP
Institution: Suven Life Sciences (India)
Language: English
Subfield: Cognitive Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7160608245
FWCI:
Cites:
Cited by:
Related to:
